CellSource Co Ltd
TSE:4880
Net Margin
CellSource Co Ltd
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Country | JP |
Market Cap | 27B JPY |
Net Margin |
18%
|
Country | US |
Market Cap | 218.6B USD |
Net Margin |
14%
|
Country | US |
Market Cap | 191.6B USD |
Net Margin |
18%
|
Country | US |
Market Cap | 43.4B USD |
Net Margin |
18%
|
Country | US |
Market Cap | 41.3B USD |
Net Margin |
9%
|
Country | CH |
Market Cap | 35.7B CHF |
Net Margin |
10%
|
Country | KR |
Market Cap | 53T KRW |
Net Margin |
23%
|
Country | US |
Market Cap | 31.1B USD |
Net Margin |
21%
|
Country | IE |
Market Cap | 26.5B USD |
Net Margin |
8%
|
Country | US |
Market Cap | 23.9B USD |
Net Margin |
19%
|
Country | US |
Market Cap | 19.7B USD |
Net Margin |
21%
|
Profitability Report
View the profitability report to see the full profitability analysis for CellSource Co Ltd.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on CellSource Co Ltd's most recent financial statements, the company has Net Margin of 18.4%.